(1993; 36 pages)
7. Development of globally acceptable standards for excipients
The Committee recommended that WHO should use its worldwide channels of communication to inform interested parties of the action being taken to harmonize the specifications for certain excipients in the European Pharmacopoeia, the Japanese Pharmacopoeia and the United States Pharmacopoeia. Those so informed should send any comments on the proposed harmonized specifications to whichever of the three pharmacopoeial authorities was taking the lead on the monograph in question. Once such harmonized texts were adopted by the three pharmacopoeias, the need for a monograph in The international pharmacopoeia or, where such a monograph existed, for its revision, could be considered.